Follow
AlzeCure Pharma AB
Nasdaq First North GM (Sweden)
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops five drug candidates within its two research platforms NeuroRestore and Alzstatin.
Sector:
HEALTH CARE
>
Drug Manufacturers - Specialty & Generic
Healthcare
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ALZCUR
SE0010133785
Nasdaq First North GM
Sweden (SE)
Details of share in AlzeCure Pharma AB with ticker ALZCUR
Status
Active
Order book id
Amount of instruments
37 765 715
Par value
0.0250
Currency
SEK
Segment
First North Premier
First trading date
28 Nov 2018
Type
Price
Pre-money
Time
Files
IPO
14.00 SEK
328.7M SEK
07 Nov - 16 Nov 2018
IPO in AlzeCure Pharma AB
People
Martin Jönsson
CEO
Thomas Pollare
Chairman of the board
Ellen Donnelly
Board member
Ragnar Linder
Board member
Pirkko Sulila Tamsen
Board member
Thomas Pollare
Board member
Company Details
Sector
HEALTH CARE

Address
Hälsovägen 7
Zip code
141 57
City/district
Huddinge
Country
Sweden (SE)
Registration number
559094-8302
LEI code
5493001EJLEBXFY6I446
First trade date
28 Nov 2018
Registration date
29 Dec 2016
Short name
AlzeCure

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More